Park Ha Biological Technology reported revenue growth of -521.29% and asset growth of 27.92% for the quarter ended Apr 2026. These growth metrics cover 3 quarters of results from Oct 2024 through Apr 2026, standardized by Business Quant from the company’s SEC filings.
| Growth Metrics | Oct2024 | Oct2025 | Apr2026 |
|---|---|---|---|
| Growth Ratios | |||
| Assets Growth (1y) | 36.14% | 93.06% | 27.92% |
| Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y) | -47.03% | 591.82% | -53.54% |
| Property, Plant & Equipment (Net) Growth (1y)PP&E (Net) Growth (1y) | 169.53% | 51.98% | 234.32% |
| Revenue Growth (1y) | -521.29% | ||
| Total Debt Growth (1y) | 15,855.93% | -305.37% | -5,527.38% |